Xilio Therapeutics, Inc.XLONASDAQ
Loading
Shares Out (Diluted) Over TimeExpanding
Percentile Rank100
3Y CAGR+249.6%
5Y CAGR+367.5%
Studio
Year-over-Year Change

Weighted average diluted shares outstanding

3Y CAGR
+249.6%/yr
Annual compound
5Y CAGR
+367.5%/yr
Recent deceleration
Percentile
P100
Near historical high
vs 5Y Ago
2234.3x
Strong expansion
Streak
6 yr
Consecutive growthExpanding
PeriodValueYoY Change
202583591090.00+2087.0%
20243822244.57+94.6%
20231964007.64+0.4%
20221956577.64+388.6%
2021400450.57+970.3%
202037413.29+28.0%
201929235.93-